Bank Julius Baer & Co
UTHR icon

Bank Julius Baer & Co’s United Therapeutics UTHR Stock Holding History

Bank Julius Baer & Co’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Sell
5,469
-241
-4% -$120K 0.01% 273
2025
Q4 		$2.83M Sell
5,710
-542
-9% -$252K 0.01% 280
2025
Q3 		$2.62M Buy
+6,252
New +$2.1M 0.01% 302
2021
Q1 		– Sell
-283
Closed -$43K – 902
2020
Q4 		$43K Buy
+283
New +$37.1K ﹤0.01% 703

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank Julius Baer & Co's UTHR Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its United Therapeutics (UTHR) stake by 4.2% in Q1 2026, selling an estimated $120K and leaving 5,469 shares worth $3.22M. The position accounts for 0.01% of the portfolio, ranked #273.

Bank Julius Baer & Co first reported a position in UTHR in Q4 2020 and has held it in 4 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Bank Julius Baer & Co held 5,469 shares of United Therapeutics worth $3.22M as of Q1 2026.
  • Bank Julius Baer & Co sold 241 United Therapeutics shares in Q1 2026, an estimated $120K.
  • United Therapeutics made up 0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #273 holding.
  • Bank Julius Baer & Co first reported a position in United Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.